X-LINKED HYPOPHOSPHATEMIA

Clinical trials for X-LINKED HYPOPHOSPHATEMIA explained in plain language.

Never miss a new study

Get alerted when new X-LINKED HYPOPHOSPHATEMIA trials appear

Sign up with your email to follow new studies for X-LINKED HYPOPHOSPHATEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3

New shot tested for rare Bone-Weakening disease

Disease control Recruiting now

This is the first study in people to test an experimental drug called KK8123, given as an injection under the skin. It aims to find a safe and tolerable dose for adults with X-linked hypophosphatemia (XLH), a rare genetic disorder that causes weak bones and low phosphate levels. …

Matched conditions: X-LINKED HYPOPHOSPHATEMIA

Phase: PHASE1, PHASE2 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

X-LINKED HYPOPHOSPHATEMIA

Get alerted when new X-LINKED HYPOPHOSPHATEMIA trials appear

New shot tested for rare Bone-Weakening disease